Answer
From week 20 onward, dexketoprofen in Skudexa may reduce amniotic fluid (oligohydramnios) through foetal renal dysfunction, potentially shortly after treatment starts and usually reversibly after discontinuation; Skudexa is contraindicated in pregnancy.
Sources for this answer
- Skudexa 75 mg/25 mg film-coated tabletsA. Menarini Farmaceutica Internazionale SRL · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 12Document updated
Sources checked